| Characterization of virus-mediated immunogenic cancer cell death and the consequences for oncolytic virus-based immunotherapy of cancer J Ma, M Ramachandran, C Jin, C Quijano-Rubio, M Martikainen, D Yu, ... Cell death & disease 11 (1), 48, 2020 | 132 | 2020 |
| In Situ Transforming RNA Nanovaccines from Polyethylenimine Functionalized Graphene Oxide Hydrogel for Durable Cancer Immunotherapy Y Yin, X Li, H Ma, J Zhang, D Yu, R Zhao, S Yu, G Nie, H Wang Nano Letters 21 (5), 2224-2231, 2021 | 128 | 2021 |
| CD93 promotes β1 integrin activation and fibronectin fibrillogenesis during tumor angiogenesis R Lugano, K Vemuri, D Yu, M Bergqvist, A Smits, M Essand, S Johansson, ... The Journal of clinical investigation 128 (8), 3280-3297, 2018 | 109 | 2018 |
| Separable microneedle patch to protect and deliver DNA nanovaccines against COVID-19 Y Yin, W Su, J Zhang, W Huang, X Li, H Ma, M Tan, H Song, G Cao, S Yu, ... ACS nano 15 (9), 14347-14359, 2021 | 80 | 2021 |
| Safe engineering of CAR T cells for adoptive cell therapy of cancer using long‐term episomal gene transfer C Jin, G Fotaki, M Ramachandran, B Nilsson, M Essand, D Yu EMBO molecular medicine 8 (7), 702-711, 2016 | 68 | 2016 |
| Pleiotrophin promotes vascular abnormalization in gliomas and correlates with poor survival in patients with astrocytomas L Zhang, S Kundu, T Feenstra, X Li, C Jin, L Laaniste, TEA El Hassan, ... Science signaling 8 (406), ra125-ra125, 2015 | 63 | 2015 |
| Double-detargeted oncolytic adenovirus shows replication arrest in liver cells and retains neuroendocrine cell killing ability J Leja, B Nilsson, D Yu, E Gustafson, G Åkerström, K Öberg, ... PLoS One 5 (1), e8916, 2010 | 63 | 2010 |
| Safe and effective treatment of experimental neuroblastoma and glioblastoma using systemically delivered triple microRNA-detargeted oncolytic semliki forest virus M Ramachandran, D Yu, M Dyczynski, S Baskaran, L Zhang, A Lulla, ... Clinical Cancer Research 23 (6), 1519-1530, 2017 | 58 | 2017 |
| CD4+ T cell-induced inflammatory cell death controls immune-evasive tumours B Kruse, AC Buzzai, N Shridhar, AD Braun, S Gellert, K Knauth, J Pozniak, ... Nature 618 (7967), 1033-1040, 2023 | 56 | 2023 |
| Adenovirus serotype 5 vectors with Tat-PTD modified hexon and serotype 35 fiber show greatly enhanced transduction capacity of primary cell cultures D Yu, C Jin, M Ramachandran, J Xu, B Nilsson, O Korsgren, K Le Blanc, ... PLoS One 8 (1), e54952, 2013 | 50 | 2013 |
| Adenovirus with hexon Tat-protein transduction domain modification exhibits increased therapeutic effect in experimental neuroblastoma and neuroendocrine tumors D Yu, C Jin, J Leja, N Majdalani, B Nilsson, F Eriksson, M Essand Journal of virology 85 (24), 13114-13123, 2011 | 48 | 2011 |
| Chondroitin Sulfate‐Coated DNA‐Nanoplexes Enhance Transfection Efficiency by Controlling Plasmid Release from Endosomes: A New Insight into Modulating Nonviral Gene Transfection H Yan, OP Oommen, D Yu, J Hilborn, H Qian, OP Varghese Advanced Functional Materials 25 (25), 3907-3915, 2015 | 44 | 2015 |
| The Tardigrada fauna of China with descriptions of three new species of Echiniscidae XC Li, LZ Wang, D Yu ZOOLOGICAL STUDIES-TAIPEI- 46 (2), 135, 2007 | 44 | 2007 |
| An infection-enhanced oncolytic adenovirus secreting H. pylori neutrophil-activating protein with therapeutic effects on neuroendocrine tumors M Ramachandran, D Yu, A Wanders, M Essand, F Eriksson Molecular Therapy 21 (11), 2008-2018, 2013 | 42 | 2013 |
| Multiple nuclear-replicating viruses require the stress-induced protein ZC3H11A for efficient growth S Younis, W Kamel, T Falkeborn, H Wang, D Yu, R Daniels, M Essand, ... Proceedings of the National Academy of Sciences 115 (16), E3808-E3816, 2018 | 41 | 2018 |
| Vector-encoded Helicobacter pylori neutrophil-activating protein promotes maturation of dendritic cells with Th1 polarization and improved migration M Ramachandran, C Jin, D Yu, F Eriksson, M Essand The Journal of Immunology 193 (5), 2287-2296, 2014 | 38 | 2014 |
| Inhibition of Heparanase in Pediatric Brain Tumor Cells Attenuates their Proliferation, Invasive Capacity, and In Vivo Tumor Growth A Spyrou, S Kundu, L Haseeb, D Yu, T Olofsson, K Dredge, E Hammond, ... Molecular Cancer Therapeutics 16 (8), 1705-1716, 2017 | 36 | 2017 |
| Oncolytic adenovirus modified with somatostatin motifs for selective infection of neuroendocrine tumor cells J Leja, D Yu, B Nilsson, L Gedda, A Zieba, T Hakkarainen, G Åkerström, ... Gene therapy 18 (11), 1052-1062, 2011 | 36 | 2011 |
| CAR T cells expressing a bacterial virulence factor trigger potent bystander antitumour responses in solid cancers C Jin, J Ma, M Ramachandran, D Yu, M Essand Nature Biomedical Engineering 6 (7), 830-841, 2022 | 35 | 2022 |
| Allogeneic lymphocyte-licensed DCs expand T cells with improved antitumor activity and resistance to oxidative stress and immunosuppressive factors C Jin, D Yu, V Hillerdal, AC Wallgren, A Karlsson-Parra, M Essand Molecular Therapy-Methods & Clinical Development 1, 2014 | 33 | 2014 |
Magnus EssandProfessor of Gene Therapy, Uppsala UniversityVerified email at igp.uu.se
